Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule

Vaccine

Volumn 32, Issue 19, 2014, Pages 2160-2166

  Silvestre, Bruna T ^a   Rabelo, Élida M L ^a   Versiani, Alice F ^a   da Fonseca, Flávio G ^a   Silveira, Júlia A G ^a   Bueno, Lilian L ^a   Fujiwara, Ricardo T ^a   Ribeiro, Múcio F B ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Anaplasma marginale; Carbon nanotubes; RMSP1a; Vaccine

Indexed keywords

ADJUVANT; ANAPLASMOSIS VACCINE; CD4 ANTIGEN; HERMES ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; L SELECTIN; MULTI WALLED NANOTUBE; NANOCARRIER; RECOMBINANT MSP1A; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; AMINO TERMINAL SEQUENCE; ANAPLASMA MARGINALE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; BLOOD SAMPLING; CATTLE; CELL PROLIFERATION ASSAY; CELLULAR IMMUNITY; CONTROLLED STUDY; COVALENT BOND; DRUG EFFICACY; ESCHERICHIA COLI; EVALUATION STUDY; FEMALE; HOST PATHOGEN INTERACTION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOPHENOTYPING; MOUSE; NICKEL AFFINITY CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL;

ANAPLASMA MARGINALE; CARBON NANOTUBES; RMSP1A; VACCINE;

ANAPLASMA MARGINALE; ANAPLASMOSIS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CELLS, CULTURED; CYTOKINES; DRUG CARRIERS; EPITOPES; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MICE, INBRED BALB C; NANOTUBES, CARBON; RECOMBINANT PROTEINS; SPLEEN; T-LYMPHOCYTES;

EID: 84897116184     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.062     Document Type: Article

References (43)

1. Ristic M., Carson C.A. Methods of immunoprophilaxis against bovine anaplasmosis with emphasis on use of the attenuated Anaplasma marginale vaccine. Immunity to blood parasites of animal and man: advances in experimental medicine and biology 1977, 151-188. Plenum Publishing Corp, New York. L.H. Miller, J.A. Pino, J.J. McKelvey (Eds.).
2. Kuttler K.L. Anaplasma infections in wild and domestic ruminants - a review. J Wildl Dis 1984, 20(1):12-20.
3. Kocan K.M., de la Fuente J., Blouin E.F., Coetzee J.F., Ewing S.A. The natural history of Anaplasma marginale. Vet Parasitol 2010, 167(2-4):95-107.
4. Lasmar P.V.F., Carvalho A.U., Filho E.J.F., Bastos C.V., Ribeiro M.F.B. Evaluating the effectiveness of an inactivated vaccine from Anaplasma marginale derived from tick cell culture. Rev Bras Parasitol Vet 2012, 21(2):112-117.
5. Palmer G.H., Barbet A.F., Davis W.C., McGuire T.C. Immunization with an isolate-common surface protein protects cattle against anaplasmosis. Science 1986, 231(4743):1299-1302.
6. Palmer G.H., Oberle S.M., Barbet A.F., Goff W.L., Davis W.C., McGuire T.C. Immunization of cattle with a 36-kilodalton surface protein induces protection against homologous and heterologous Anaplasma marginale challenge. Infect Immun 1988, 56(6):1526-1531.
7. Palmer G.H., Barbet A.F., Cantor G.H., McGuire T.C. Immunization of cattle with the msp-1 surface protein complex induces protection against a structurally variant Anaplasma marginale isolate. Infect Immun 1989, 57(11):3666-3669.
8. Tebele N., McGuire T.C., Palmer G.H. Induction of protective immunity by using Anaplasma marginale initial body membranes. Infect Immun 1991, 59(9):3199-3204.
9. McGuire T.C., Stephens E.B., Palmer G.H., Mcelwain T.F., Lichtensteiger C.A., Leib S.R., et al. Recombinant vaccinia virus expression of Anaplasma marginale surface protein msp-1a - effect of promoters, leader sequences and gpi anchor sequence on antibody-response. Vaccine 1994, 12(5):465-471.
10. Brown W.C., Shkap V., Zhu D., McGuire T.C., Tuo W., Mcelwain T.F., et al. T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect Immun 1998, 66:5406-5413.
11. Brown W.C., Palmer G.H., Lewin H.A., McGuire T.C.C.D4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains. Infect Immun 2001, 69(11):6853-6862.
12. de la Fuente J., Garcia-Garcia J.C., Blouin E.F., Kocan K.M. Characterization of the functional domain of major surface protein 1a involved in adhesion of the rickettsia Anaplasma marginale to host cells. Vet Microbiol 2003, 91(2/3):265-283.
13. Kocan K.M., de la Fuente J., Guglielmone A.A., Melendez R.D. Antigens and alternatives for control of Anaplasma marginale infection in cattle. Clin Microbio Rev 2003, 16(4):698-712.
14. McGarey D.J., Barbet A.F., Palmer G.H., McGuire T.C., Allred D.R. Putative adhesins of Anaplasma marginale - major surface polypeptides 1a and 1b. Infect Immun 1994, 62(10):4594-4601.
15. McGarey D.J., Allred D.R. Characterization of hemagglutinating components on the Anaplasma marginale initial body-surface and identification of possible adhesins. Infect Immun 1994, 62(10):4587-4593.
16. Palmer G.H., Waghela S.D., Barbet A.F., Davis W.C., McGuire T.C. Characterization of a neutralization-sensitive epitope on the am-105 surface protein of Anaplasma marginale. Int J Parasitol 1987, 17(7):1279-1285.
17. de la Fuente J., Garcia-Garcia J.C., Blouin E.F., Kocan K.M. Differential adhesion of major surface proteins 1a and 1b of the ehrlichial cattle pathogen Anaplasma marginale to bovine erythrocytes and tick cells. Int J Parasitol 2001, 31(2):145-153.
18. Garcia-Garcia J.C., de la Fuente J., Kocan K.M., Blouin E.F., Halbur T., Onet V.C., et al. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens. Vet Immunol Immunopathol 2004, 98(3-4):137-151.
19. Foldvari M., Bagonluri M. Carbon nanotubes as functional exipients for nanomedicines. II. Drug delivery and biocompatibility issues. Nanomedicine 2008, 4(3):183-200.
20. Pantarotto D., Partidos C.D., Hoebeke J., Brown F., Kramer E., Briand J.P., et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol 2003, 10:961-966.
21. Bianco A., Kostarelos K., Partidos C.D., Prato M. Biomedical applications of functionalised carbon nanotubes. Chem Commun (Camb) 2005, 5:571-577.
22. Yandar N., Pastorin G., Prato M., Bianco A., Patarroyo M.E., Lozano J.M. Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model. Vaccine 2008, 26:5864-5873.
23. Bastos C.V., Passos L.M., Facury-Filho E.J., Rabelo E.M., Fuente Jde L., Ribeiro M.F. Protection in the absence of exclusion between two Brazilian isolates of Anaplasma marginale in experimentally infected calves. Vet J 2010, 186(3):374-378.
24. Jiang K., Schadler L.S., Siegel R.W., Zhang X., Zhang H., Terrones M. Protein immobilization on carbon nanotubes via a two-step process of diimide-activated amidation. J Mater Chem 2003, 14:37-39.
25. Kocan K.M., Halbur T., Blouin E.F., Onet V., de la Fuente J., Garcia-Garcia J.C., et al. Immunization of cattle with Anaplasma marginale derived from tick cell culture. Vet Parasitol 2001, 102(1/2):151-161.
26. de la Fuente J., Kocan K.M., Garcia-Garcia J.C., Blouin E.F., Claypool P.L., Saliki J.T. Vaccination of cattle with Anaplasma marginale derived from tick cell culture and bovine erythrocytes followed by challenge-exposure with infected ticks. Vet Microbiol 2002, 89(2-3):239-251.
27. Noh S.M., Turse J.E., Brown W.C., Norimine J., Palmer G.H. Linkage between Anaplasma marginale outer membrane proteins enhances immunogenicity but is not required for protection from challenge. Clin Vaccine Immunol 2013, 20(5):651-656.
28. Pantarotto D., Briand J.P., Prato M., Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun (Camb) 2004, 10(1):16-17.
29. Kam N.W., Jessop T.C., Wender P.A., Dai H. Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J Am Chem Soc 2005, 126:6850-6851.
30. Astigarraga R.G. Desenvolvimento e avaliação imunológica de Nanotubos de Carbono funcionalizados com a proteína de envelope de Dengue vírus 3 2012, [dissertation], Federal University of Minas Gerais.
31. Brown W.C., Zhu D., Shkap V., McGuire T.C., Blouin E.F., Kocan K.M., et al. The repertoire of Anaplasma marginale antigens recognized by CD4+ T-lymphocyte clones from protectively immunized cattle is diverse and includes major surface protein 2 (MSP-2) and MSP-3. Infect Immun 1998, 66:5414-5422.
32. Palmer G.H., Rurangirwa F.R., Kocan K.M., Brown W.C. Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale. Parasitol Today 1999, 15:281-286.
33. Kawasaki P.M., Kano F.S., Tamekuni K., Garcia J.L., Marana E.R.M., Vidotto O., et al. Immune response of BALB/c mouse immunized with recombinant MSPs proteins of Anaplasma marginale binding to immunostimulant complex (ISCOM). Res Vet Sci 2007, 347-354.
34. Kano F.S., Tamekuni K., Coelho A.L., Garcia J.L., Vidotto O., Itano E.N., et al. Induced immune response of DNA vaccine encoding an association MSP1a, MSP1b, and MSP5 antigens of Anaplasma marginale. Vaccine 2008, 26:3522-3527.
35. Santos P.S., Sena A.A.S., Nascimento R., Araújo T.G., Mendes M.M., Martins J.R.S., et al. Epitope-based vaccines with the Anaplasma marginale MSP1a functional motif induce a balanced humoral and cellular immune response in mice. PLoS ONE 2013, 8(4):e60311.
36. Feng H.M., Popov V.L., Walker D.H. Depletion of gamma interferon and tumor necrosis factor alpha in mice with rickettsia conorii-infected endothelium: impairment of rickettsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease. Infect Immun 1994, 62(5):1952-1960.
37. Shoda L.K.M., Kegerreis K.A., Suarez C.E., Mwangi W., Knowles D.P., Brown W.C. Immunostimulatory CpC-modified plasmid DNA enhances IL-12, TNF-α and NO production by bovine macrophages. J Leukocyte Biol 2001, 70:103-112.
38. Akkoyunlu M., Fikrig E. Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect Immun 2000, 68:1827-1833.
39. Ojogun N., Barnstein B., Huang B., Oskeritzian C.A., Homeister J.W., Miller D., et al. Anaplasma phagocytophilum infects mast cells via α1,3-fucosylated but not sialylated glycans and inhibits IgE-mediated cytokine production and histamine release. Infect Immun 2011, 79(7):2717-2726.
40. Jin W., Dong C. IL-17 cytokines in immunity and inflammation. EMI 2013, 2:e60.
41. Hamada S., Umemura M., Shiono T., Tanaka K., Yahagi A., Begum M.D., et al. IL-17A produced by gamma delta T cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver. J Immunol 2008, 181:3456-3463.
42. Lockhart E., Green A.M., Flynn J.L. IL-17 production is dominated by gamma delta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 2006, 177:4662-4669.
43. Raffatellu M., Santos R.L., Verhoeven D.E., George M.D., Wilson R.P., Winter S., et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008, 14:421-428.